HIV may have returned in 'cured' patient: scientists

An American man whose HIV seemed to disappear after a blood marrow transplant for leukemia may be showing new hints of the disease, sparking debate over whether a cure was really achieved.

Scientists disagree over the latest findings on Timothy Brown, also known as the "Berlin patient," presented at a conference in Spain last week, according to a report in the journal Science's ScienceInsider blog.

Brown was given in 2006 that appeared to eradicate the from his body, leading his doctors to declare a "cure of has been achieved" in the peer-reviewed journal Blood in 2010.

The transplants came from a donor with an unusual genetic mutation that is naturally resistant to HIV. About one in 100 people have this mutation which prevents the molecule CCR5 from appearing on the .

The latest debate arose after virologist Steven Yukl of the University of California, San Francisco, gave a talk on June 8 at the International Workshop on HIV & Hepatitis Virus.

Yukl "highlighted the difficulties that they and several labs they collaborated with have had determining if Brown truly had eradicated the virus from his body," said the ScienceInsider report.

"There are some signals of the virus and we don't know if they are real or contamination, and, at this point, we can't say for sure whether there's been complete eradication of HIV," Yukl was quoted as saying by ScienceInsider.

"The point of the presentation was to raise the question of how do we define a cure and, at this level of detection, how do we know the signal is real?"

However, some scientists interpreted the presentation to mean that a cure was not actually achieved, and that Brown may even have been re-infected with the virus that causes AIDS.

Alain Lafeuillade of the General Hospital in Toulon, France, issued a press release that described how Yukl and colleagues "challenged these results as they showed persistence of low levels of HIV viremia in this patient, and HIV DNA in his rectal cells."

He noted that "these HIV strains were found to be different from those initially present in this patient back in 2006, and different from each other."

While that could mean the HIV has "evolved and persist(ed) over the last 5 years, these data also raise the possibility that the patient has been re-infected," Lafeuillade wrote.

"More studies are in progress to know if this seronegative HIV individual can infect other subjects if he has unsafe sex," he concluded.

Yukl, quoted by ScienceInsider, said Lafeuillade misinterpreted the presentation.

""We weren't trying to say HIV was still there or he hadn't been cured," he said, noting the talk centered on how to interpret very sensitive test results on Brown's blood cells, plasma and rectal tissue.

One of his collaborators, Douglas Richman of the University of California, San Diego, said he believes researchers have picked up contaminants.

"If you do enough cycles of PCR (polymerase chain reaction), you can get a signal in water for pink elephants," Richman was quoted as saying.

add to favorites email to friend print save as pdf

Related Stories

Gene therapy reduces HIV levels in small trials

Sep 20, 2011

(Medical Xpress) -- This weekend at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago, Illinois, researchers from two different study groups, one on the east coast and one on the west coast, ...

30 years after first AIDS cases, hope for a cure

Jun 03, 2011

(AP) -- Sunday marks 30 years since the first AIDS cases were reported in the United States. And this anniversary brings fresh hope for something many had come to think was impossible: finding a cure.

Report: Transplant may have cured man of AIDS

Dec 15, 2010

A very unusual blood transplant appears to have cured an American man living in Berlin of infection with the AIDS virus, but doctors say the approach is not practical for wide use. The man, who is in his 40s, had a blood ...

FDA approves antiretroviral drug

Aug 07, 2007

The U.S. Food and Drug Administration has approved the antiretroviral drug maraviroc for use in adult human immunodeficiency virus patients.

A cure for HIV could be all in the 'mix'

Aug 18, 2010

Current HIV treatments do not eradicate HIV from host cells but rather inhibit virus replication and delay the onset of AIDS. However, a new research published in BioMed Central's open access journal, AIDS Research & Therapy descri ...

Recommended for you

Respect may be the key to stopping patient 'no shows'

18 hours ago

People with HIV are more likely to keep their scheduled medical appointments—and their disease under control—if they feel their physician listens, explains things clearly and knows them as a person, not just a "case," ...

Study details age disparities in HIV continuum of care

Jun 17, 2013

Age disparities exist in the continuum of care for patients with the human immunodeficiency virus (HIV) with people younger than 45 years less likely to be aware of their infection or to have a suppressed viral load, according ...

Cost-effective: Universal HIV testing in India

Jun 10, 2013

In India most people who are HIV positive don't know it, yet testing and treatment are relatively cheap and available. It would therefore meet international standards of cost-effectiveness—and save millions of lives for ...

User comments

More news stories

Taxing unhealthy food spurs people to buy less

Labeling foods and beverages as less-healthy and taxing them motivates people to make healthier choices, finds a recent study in the American Journal of Preventive Medicine. When faced with a 30 percent tax on ...

Renewed hope in a once-abandoned cancer drug class

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments ...

New technologies for retinal therapies

The future of the investigation and treatment of retinal disorders is already here at the MedUni Vienna: in the new Christian Doppler "OPTIMA" (Ophthalmic Image Analysis) laboratory headed by Ursula Schmidt-Erfurth, ...

Laughing gas does not increase heart attacks

(Medical Xpress)—Nitrous oxide—best known as laughing gas—is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk ...

Model recreates wear and tear of osteoarthritis

(Medical Xpress)—There's a reason osteoarthritis is often called wear-and-tear arthritis: Repeated stress on joints over time results in degeneration of the soft cartilage that normally distributes loads ...